Skip to content

Azatadine

Published: July 26, 2026Updated: August 20, 2026

Azatadine is a second-generation antihistamine used to relieve symptoms of allergic conditions such as seasonal allergic rhinitis and chronic urticaria. It works by blocking histamine H1 receptors, reducing allergic symptoms like sneezing, itching, and runny nose. This medication has been available in oral form and is typically used in adults and children.

Quick summary

Azatadine is an antihistamine used to treat allergic rhinitis and other allergic reactions.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ATC
R06AX09
RxNorm
18600
Generic
Azatadine
Class
atc-r06
Brands
—
Availability
rx
Lactation
unknown
Routes
oral
Forms
tablet
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Dosage and administration

adult (standard)tablet
Usual dose
500mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
pediatric (standard)tablet
Usual dose
250mg twice daily
Maximum
consult physician
Frequency
every 12 hours
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard
geriatric (standard)tablet
Usual dose
400mg daily
Maximum
consult physician
Frequency
once daily
Instructions
Follow physician instructions
Duration limits
as prescribed
Monitoring
standard

Overdose information

Important overdose information
Toxic dose: Single dose that may cause serious toxicity in adults
Chronic overdose: Prolonged use exceeding recommended dosage may lead to cumulative toxicity
Immediate actions
Gastric lavage within 1-2 hours of ingestion, activated charcoal administration, supportive care, monitoring of vital signs
Antidote
No specific antidote available; physostigmine may be considered for severe anticholinergic toxicity(Supportive care is primary treatment; physostigmine can reverse anticholinergic effects if administered early)
Poison Control: 1-800-222-1222

Special Populations

11 groups
⚠

pregnancy

first trimester
caution
FDA Category
C
Dose Adjustment

avoid if possible

Key Recommendations

avoid use during pregnancy unless benefits outweigh risks, use only if clearly necessary

Monitor

regular prenatal monitoring

Use with caution and monitor for adverse effects.

⚠

pregnancy

second trimester
caution
FDA Category
C
Dose Adjustment

avoid if possible

Key Recommendations

use only if benefits outweigh potential risks

Monitor

regular prenatal monitoring

Use with caution and monitor for adverse effects.

⚠

pregnancy

third trimester
caution
FDA Category
C
Dose Adjustment

avoid if possible

Key Recommendations

avoid close to delivery due to potential effects on newborn

Monitor

fetal monitoring in late pregnancy

Use with caution and monitor for adverse effects.

⚠

lactation

breastfeeding
caution
FDA Category
C
Dose Adjustment

use with caution

Key Recommendations

azatadine may pass into breast milk, use alternative antihistamines with better safety data or discontinue breastfeeding

Monitor

monitor infant for excessive drowsiness

Use with caution and monitor for adverse effects.

⚠

geriatric

elderly
caution
FDA Category
C
Dose Adjustment

reduce dose, start with lowest effective dose

Key Recommendations

use with caution due to increased sensitivity to anticholinergic effects, increased risk of sedation and cognitive impairment

Monitor

monitor for sedation, confusion, anticholinergic effects

Use with caution and monitor for adverse effects.

⚠

pediatric_age

children under 12
caution
FDA Category
C
Dose Adjustment

not recommended for children under 12 years

Key Recommendations

safety and efficacy not established in children under 12, use alternative antihistamines with pediatric dosing data

Monitor

monitor for paradoxical excitement or sedation

Use with caution and monitor for adverse effects.

⚠

renal_impairment

mild to moderate
caution
FDA Category
C
Dose Adjustment

reduce dose by 25-50%

Key Recommendations

use with caution, dose adjustment recommended based on creatinine clearance

Monitor

monitor renal function periodically

Use with caution and monitor for adverse effects.

✗

renal_impairment

severe
unsafe
FDA Category
C
Dose Adjustment

avoid or use significantly reduced dose

Key Recommendations

not recommended in severe renal impairment unless benefits outweigh risks

Monitor

close monitoring of renal function and drug levels

Use of this medication in this population requires careful consideration of risks and benefits.

⚠

hepatic_impairment

mild to moderate
caution
FDA Category
C
Dose Adjustment

reduce dose by 25-50%

Key Recommendations

use with caution, dose adjustment may be needed due to altered metabolism

Monitor

monitor liver function tests

Use with caution and monitor for adverse effects.

⚠

hepatic_impairment

severe
caution
FDA Category
C
Dose Adjustment

avoid or use significantly reduced dose

Key Recommendations

use with extreme caution in severe hepatic impairment

Monitor

monitor liver function and for signs of toxicity

Use with caution and monitor for adverse effects.

✗

alcohol_users

concurrent alcohol use
unsafe
FDA Category
C
Dose Adjustment

avoid concomitant use

Key Recommendations

avoid alcohol while taking azatadine due to enhanced sedative effects

Monitor

monitor for excessive sedation and impaired coordination

Use of this medication in this population requires careful consideration of risks and benefits.

Statistics and clinical data

prescribingN/A
2026

Commonly prescribed since

Value:N/A

No prescribing data available for this compound

drug_classN/A
2026

Drug class

Value:N/A

No classification data available

usageN/A
2026

Common uses

Value:N/A

No therapeutic use data available

regulatory_statusFDA
2023

Regulatory approval

Value:Not approved

No FDA-approved drug named Azatadine found in database

Treatment of seasonal and perennial allergic rhinitis (hay fever), allergic conjunctivitis, chronic urticaria (hives), and other allergic skin conditions characterized by itching and rash.

Azatadine is a selective histamine H1 receptor antagonist that blocks the action of histamine, a substance released during allergic reactions. By preventing histamine from binding to its receptors, it reduces allergic symptoms including sneezing, itching, nasal discharge, and skin reactions.

May cause drowsiness, dry mouth, and blurred vision. Use with caution in patients with glaucoma, urinary retention, or thyroid disorders. Avoid alcohol and CNS depressants while taking this medication. Consult healthcare provider before use if pregnant, breastfeeding, or giving to children.

Contraindications

Conditions and patient states where this medication should be avoided or used with caution.

Do not use (1)

ABSOLUTEhypersensitivity

Known allergy to this medication or its components

Use caution (1)

RELATIVEpregnancy

Consult healthcare provider for benefits vs risks assessment

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy